DCW Limited — Investor Meet, 19-05-2025: Analysts/Institutional Investor Meet/Con. Call Updates

DCW has announced a board meeting to consider the financial results for the quarter and half-year.

Q4 revenue fell 13% YoY to INR 538 Cr, hit by pricing pressure and weak exports in basic chemicals; specialty chemicals held steady at INR 125 Cr. FY25 revenue rose 7% to INR 2,000 Cr, with specialty up 43% and basic chemicals down 2%. Q4 EBITDA declined 10.5% to INR 62 Cr due to basic chemicals margin pressure; FY25 EBITDA grew 12% to INR 217 Cr led by specialty’s 41% rise. PAT doubled to INR 30 Cr on lower finance costs; net debt/EBITDA fell below 1x. Specialty expansion and cost efficiencies underpin a cautiously optimistic outlook targeting FY27 EBITDA of ~INR 400 Cr, driven by specialty growth and volume improvement.